Research ArticleOncology
18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2− Metastatic Breast Cancer
Lanell M. Peterson, Brenda F. Kurland, Fengting Yan, Alena Novakova- Jiresova, Vijayakrishna K. Gadi, Jennifer M. Specht, Julie R. Gralow, Erin K. Schubert, Jeanne M. Link, Kenneth A. Krohn, Janet F. Eary, David A. Mankoff and Hannah M. Linden
Journal of Nuclear Medicine February 2021, 62 (2) 184-190; DOI: https://doi.org/10.2967/jnumed.120.244459
Lanell M. Peterson
1Division of Medical Oncology, University of Washington/Seattle Cancer Care Alliance, Seattle, Washington
Brenda F. Kurland
2Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania
Fengting Yan
1Division of Medical Oncology, University of Washington/Seattle Cancer Care Alliance, Seattle, Washington
Alena Novakova- Jiresova
3Department of Oncology, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic
Vijayakrishna K. Gadi
1Division of Medical Oncology, University of Washington/Seattle Cancer Care Alliance, Seattle, Washington
4Clinical Research and Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington
Jennifer M. Specht
1Division of Medical Oncology, University of Washington/Seattle Cancer Care Alliance, Seattle, Washington
Julie R. Gralow
1Division of Medical Oncology, University of Washington/Seattle Cancer Care Alliance, Seattle, Washington
Erin K. Schubert
5Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania
Jeanne M. Link
6Department of Diagnostic Radiology, Oregon Health and Science University, Portland, Oregon; and
Kenneth A. Krohn
6Department of Diagnostic Radiology, Oregon Health and Science University, Portland, Oregon; and
Janet F. Eary
7Cancer Imaging Program, National Cancer Institute, Bethesda, Maryland
David A. Mankoff
5Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania
Hannah M. Linden
1Division of Medical Oncology, University of Washington/Seattle Cancer Care Alliance, Seattle, Washington

SNMMI members
Login to the site using your SNMMI member credentials
Individuals
Login as an individual user
In this issue
Journal of Nuclear Medicine
Vol. 62, Issue 2
February 1, 2021
18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2− Metastatic Breast Cancer
Lanell M. Peterson, Brenda F. Kurland, Fengting Yan, Alena Novakova- Jiresova, Vijayakrishna K. Gadi, Jennifer M. Specht, Julie R. Gralow, Erin K. Schubert, Jeanne M. Link, Kenneth A. Krohn, Janet F. Eary, David A. Mankoff, Hannah M. Linden
Journal of Nuclear Medicine Feb 2021, 62 (2) 184-190; DOI: 10.2967/jnumed.120.244459
18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2− Metastatic Breast Cancer
Lanell M. Peterson, Brenda F. Kurland, Fengting Yan, Alena Novakova- Jiresova, Vijayakrishna K. Gadi, Jennifer M. Specht, Julie R. Gralow, Erin K. Schubert, Jeanne M. Link, Kenneth A. Krohn, Janet F. Eary, David A. Mankoff, Hannah M. Linden
Journal of Nuclear Medicine Feb 2021, 62 (2) 184-190; DOI: 10.2967/jnumed.120.244459
Jump to section
Related Articles
Cited By...
- No citing articles found.